Erin Lynch, wife of trainer Brian Lynch, was diagnosed with “stage 2, triple positive, invasive ductal carcinoma breast ...

Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

Adjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved invasive disease-free survival compared with ...

With breast cancer emerging as the most prevalent type of cancer in Indian women, it becomes crucial to understand what is ...

No matter their perceived chances, the connections of these Breeders' Cup entrants are looking forward to their opportunity ...

Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by ...

TUESDAY, Oct. 14, 2025 (HealthDay News) -- The incidence rates for invasive lobular carcinoma (ILC) increased from 2012 to 2021 for all racial and ethnic groups, according to a study published online ...

A rare but dangerous form of breast cancer is on the rise in the United States, a new report says. Lobular breast cancer rates are rising three times as fast as all other breast cancers combined, 2.8% ...

"It wasn’t until I developed a random blind spot in my eye that my mom took me to the ER. They ordered a head CT that caught ...

In HR+/HER- early breast cancer, the DFS benefits of adjuvant ribociclib plus NSAI treatment compared to NSAI alone persisted even a year after treatment completion.